Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms

被引：0

作者：

Gurban, Petruta ^{[1
,2
]}

Mambet, Cristina ^{[1
,3
,4
]}

Botezatu, Anca ^{[5
]}

Necula, Laura G. ^{[1
]}

Matei, Lilia ^{[1
]}

Neagu, Ana Iulia ^{[1
,6
]}

Pitica, Ioana ^{[1
]}

Ataman, Marius ^{[1
]}

Tatic, Aurelia ^{[1
,3
,7
]}

Bardas, Alexandru ^{[1
,3
,7
]}

Gaman, Mihnea A. ^{[1
,3
,7
]}

Dobrea, Camelia ^{[3
,7
]}

Dragomir, Mihaela ^{[7
]}

Ghimici, Cecilia ^{[8
]}

Angelescu, Silvana ^{[3
,8
]}

Barbu, Doina ^{[8
]}

Stanca, Oana ^{[3
,8
]}

Danila, Marina ^{[8
]}

Berbec, Nicoleta ^{[3
,8
]}

Colita, Andrei ^{[3
,8
]}

Vladareanu, Ana Maria ^{[3
,4
]}

Nedeianu, Saviana ^{[1
]}

Chivu-Economescu, Mihaela ^{[1
]}

Bleotu, Coralia ^{[1
]}

Coriu, Daniel ^{[1
,3
,7
]}

Sepulchre, Elise ^{[9
]}

Anton, Gabriela ^{[5
]}

Diaconu, Carmen C. ^{[1
]}

Constantinescu, Stefan N. ^{[9
,10
,11
,12
]}

机构：

[1] Romanian Acad, Stefan S Nicolau Inst Virol, Cellular & Mol Pathol Dept, Bucharest, Romania

[2] Cytogenom Med Lab, Bucharest, Romania

[3] Carol Davila Univ Med & Pharm, Fac Med, Dept Radiol Oncol & Hematol, Bucharest, Romania

[4] Emergency Univ, Clin Hosp, Hematol Dept, Bucharest, Romania

[5] Romanian Acad, Stefan S Nicolau Inst Virol, Mol Virol Dept, Bucharest, Romania

[6] Carol Davila Univ Med & Pharm, Fac Med, Infect Dis Epidemiol Microbiol Parasitol Virol Dia, Bucharest, Romania

[7] Fundeni Clin Inst, Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania

[8] Coltea Clin Hosp, Hematol Dept, Bucharest, Romania

[9] Catholic Univ Louvain, de Duve Inst, Brussels, Belgium

[10] Ludwig Inst Canc Res Brussels, SIGN Cell Signalling & Mol Hematol, Brussels, Belgium

[11] WEL Res Inst, Walloon Excellence Life Sci & Biotechnol WELBIO De, Wavre, Belgium

[12] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Med, Oxford, England

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2025年 / 100卷 / 01期

关键词：

D O I：

10.1002/ajh.27503

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：168 / 171

页数：4

共 50 条

[21] Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms
Guy, Alexandre
Poisson, Johanne
James, Chloe
LEUKEMIA, 2021, 35 (04) : 935 - 955
[22] Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms
Alexandre Guy
Johanne Poisson
Chloe James
Leukemia, 2021, 35 : 935 - 955
[23] Conformation sensitive gel electrophoresis for the detection of calreticulin mutations in BCR-ABL1-negative myeloproliferative neoplasms
Zakaria, Nur Atikah
Rosle, Norfifiana Alisa
Siti Asmaa, Mat Jusoh
Aziee, Sudin
Haiyuni, Mohd Yassim
Samat, Nurul Ameera
Husin, Azlan
Hassan, Rosline
Ramli, Marini
Mohamed Yusoff, Shafini
Ibrahim, Ibrahim Khidir
Al-Jamal, Hamid Ali Nagi
Johan, Muhammad Farid
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (06) : 1451 - 1457
[24] Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms
Ding, Li
Luo, Jie
Zhang, Jing
Wang, Ji
Li, Zhao
Huang, Juan
Chai, Li
Mu, Jiao
Zhao, Beibei
Zhong, Yi
Zhang, Lin
Liu, Lin
ONCOLOGY LETTERS, 2022, 23 (01)
[25] Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm
Abbou, Norman
Piazzola, Pauline
Gabert, Jean
Ernest, Vincent
Arcani, Robin
Couderc, Anne-Laure
Tichadou, Antoine
Roche, Pauline
Farnault, Laure
Colle, Julien
Ouafik, L'houcine
Morange, Pierre
Costello, Regis
Venton, Geoffroy
CELLS, 2023, 12 (01)
[26] Increased mRNA expression for serotonin receptor 1B (HTR1B) is associated with thrombosis in BCR::ABL1-negative myeloproliferative neoplasms
Gurban, Petruta
Mambet, Cristina
Botezatu, Anca
Necula, Laura G.
Matei, Lilia
Neagu, Ana Iulia
Pitica, Ioana Madalina
Dragu, Laura Denisa
Schulman, Alina Nastasie
Ataman, Marius
Nedeianu, Saviana
Chivu-Economescu, Mihaela
Bleotu, Coralia
Anton, Gabriela
Diaconu, Carmen Cristina
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (16)
[27] Oxidant/Antioxidant Status in Patients with BCR-ABL1 Negative Myeloproliferative Neoplasms
Benguella-Benmansour, Meriem
Boucherit, Kebir
Mesli, Naima
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025, 41 (01) : 23 - 30
[28] Immunophenotypic Aberrancy on Basophils, a Biomarker for BCR-ABL1 Negative Myeloproliferative Neoplasms
Chu, Andrew
Kumar, Kirthi
Monaghan, Sara A.
Fuda, Franklin
Chen, Weina
LABORATORY INVESTIGATION, 2016, 96 : 340A - 340A
[29] Basophilia Predicts Poorer Outcomes in BCR-ABL1-Negative Myeloproliferative Neoplasms
Yuen, Lisa
Gogakos, Tasos
Boiocchi, Leonardo
Hobbs, Gabriela
Hasserjian, Robert
MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1048 - 1049
[30] The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms
Vadeikiene, Roberta
Jakstys, Baltramiejus
Laukaitiene, Danguole
Satkauskas, Saulius
Juozaityte, Elona
Ugenskiene, Rasa
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)

← 1 2 3 4 5 →